Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Go back to Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 19.83 -0.07 (0.35%)
Previous Close $19.90    52 Week High $12.48 
Open $19.51    52 Week Low $1.60 
Day High $20.62    P/E N/A 
Day Low $19.34    EPS $-6.33 
Volume 166,025